AbCellera Biologics Inc. (ABCL) on GreekSoup https://greeksoup.ai/stocks/us/abcl/ Every dated entry in the public record on AbCellera Biologics Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 AbCellera Biologics Inc.: short interest 30,934,912 shares at the 15 October 2026 settlement, 5.63 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-10-15:4ed12ad446Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: short interest 32,498,416 shares at the 30 September 2026 settlement, 5.98 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-09-30:d53e518a97Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: short interest 33,930,287 shares at the 15 September 2026 settlement, 9.63 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-09-15:6a7c551251Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: short interest 34,752,708 shares at the 31 August 2026 settlement, 5.18 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-08-31:79a71c46f3Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: Hayden Michael R (Director), see footnote, bought 53,613 shares at $10.64 on 24 August 2026, $570,442https://greeksoup.ai/stocks/us/abcl/insiders/us:ABCL:insider:2026-08-24:5634cd5762Mon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: Montalbano John S. (Director) bought 10,000 shares at $11.03 on 18 August 2026, $110,300https://greeksoup.ai/stocks/us/abcl/insiders/us:ABCL:insider:2026-08-18:e9b1250b03Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: Booth Andrew (Chief Financial Officer) bought 37,200 shares at $10.32 on 14 August 2026, $383,904https://greeksoup.ai/stocks/us/abcl/insiders/us:ABCL:insider:2026-08-14:9657f61ee5Fri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: Hayden Michael R (Director), see footnote, bought 46,387 shares at $10.37 on 12 August 2026, $481,033https://greeksoup.ai/stocks/us/abcl/insiders/us:ABCL:insider:2026-08-14:b37a25505bFri, 14 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: short interest 41,340,862 shares at the 14 August 2026 settlement, 3.04 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-08-14:533adb023eFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. filed 8-K: material agreement, other eventshttps://greeksoup.ai/stocks/us/abcl/filings/us:ABCL:filing:2026-08-13:88d83c5677Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/abcl/filings/us:ABCL:filing:2026-08-10:edcca5590aMon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/abcl/filings/us:ABCL:filing:2026-08-07:dfefdd9695Fri, 07 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. Q2 FY2026 results: revenue $4 million, net income -$55 millionhttps://greeksoup.ai/stocks/us/abcl/results/fy2026-q2/us:ABCL:result:2026-08-05:4ff1d6fc04Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/abcl/filings/us:ABCL:filing:2026-08-05:f9a5c6f302Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/abcl/filings/us:ABCL:filing:2026-08-05:b643f30705Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> AbCellera Biologics Inc.: short interest 48,318,516 shares at the 31 July 2026 settlement, 9.66 days to coverhttps://greeksoup.ai/stocks/us/abcl/short-interest/us:ABCL:short-interest:2026-07-31:617a79b398Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>